Archives
-
Toremifene Citrate for Reliable ER Assays
2026-09-15
A scenario-based guide to using Toremifene Citrate in estrogen receptor, breast cancer, and cell viability studies. It explains how SKU B1513 can support practical assay design through defined receptor activity, DMSO compatibility, concentration guidance, and storage information.
-
Restoring PTEN with Smarter mRNA Translation
2026-09-14
PTEN mRNA offers a transient, controllable route to interrogate PI3K/Akt biology and therapeutic resistance. This thought-leadership guide connects Cap1 and pseudouridine design with translational experimental strategy, using nanoparticle-mediated PTEN restoration in trastuzumab-resistant breast cancer as a mechanistic anchor.
-
Lysis Buffer for Rapid Mouse Genotyping
2026-09-14
Build a faster, more consistent mouse genotyping workflow around controlled tissue digestion and DNA release. This guide explains how to use the lysis buffer with proteinase K, improve PCR readiness, and connect reliable genotype assignment with downstream genetic research without overstating what the reagent can prove.
-
Iptacopan Monotherapy in PNH: Study Findings
2026-09-13
This phase 2 proof-of-concept study evaluated Iptacopan (LNP023), an oral factor B inhibitor, as single-agent therapy in patients with active paroxysmal nocturnal hemoglobinuria. Rapid reductions in hemolysis, improved hemoglobin, and reduced transfusion requirements support proximal alternative-pathway inhibition as a clinically relevant strategy, while the small open-label design limits comparative conclusions.
-
Tacrine hydrochloride hydrate: assay workflow
2026-09-12
Tacrine hydrochloride hydrate provides a practical benchmark for AChE and BuChE inhibition, while its simple scaffold supports cell-based neuroprotection studies and multi-target drug design. This workflow connects concentration planning, assay controls, translational readouts, and troubleshooting for more reproducible Alzheimer’s disease research.
-
Entinostat (MS-275) Cancer Research Workflows
2026-09-12
Entinostat (MS-275) enables selective class I HDAC inhibition while helping researchers separate growth arrest from actual cell killing. This workflow-centered guide covers dose-response design, chromatin readouts, retinoblastoma models, and troubleshooting for more interpretable cancer pharmacology data.
-
LRPPRC Inhibition and Dasatinib Disrupt OXPHOS
2026-09-11
A 2026 study identifies dasatinib as a synergistic partner for LRPPRC inhibition in OXPHOS-dependent cancer models. Its central insight is that the two interventions disrupt complementary OXPHOS gene programs: dasatinib preferentially affects nuclear-encoded genes, whereas LRPPRC inhibition impairs mitochondrial genome-encoded transcripts.
-
Cy5-UTP for RNA Probe Synthesis and FISH
2026-09-11
Cy5-UTP streamlines fluorescent RNA probe synthesis for FISH, multiplex imaging, and dual-color expression arrays. This practical guide connects labeling chemistry with STAU2 condensate research while emphasizing assay design, optimization, and troubleshooting.
-
ω-Agatoxin IVA in Epileptogenesis: Study Insights
2026-09-10
This Molecular Neurobiology study shows that selective blockade of P/Q-type Cav2.1 calcium channels with ω-agatoxin IVA suppresses PTZ-associated epileptogenesis in rats while shifting BDNF and cleaved caspase-3 expression toward a pro-survival profile. Its combination of behavioral, freely moving EEG, and regional immunohistochemical analyses provides a useful framework for evaluating Cav2.1 signaling in seizure biology.
-
DRB: Mechanism, Benchmarks, and RNA Polymerase II
2026-09-10
5,6-Dichloro-1-β-D-ribofuranosylbenzimidazole (DRB) is a CDK-directed transcriptional elongation inhibitor that perturbs RNA polymerase II-dependent RNA synthesis. Its benchmark activities include inhibition of CTD kinases, suppression of hnRNA production in HeLa cells, and inhibition of Tat-enhanced HIV transcription in vitro.
-
Epalrestat Workflows for Polyol Pathway Research
2026-09-09
Epalrestat provides a practical way to interrogate aldose reductase, polyol pathway flux, and redox responses across diabetic neuropathy research, neuroprotection, and exploratory cancer metabolism studies. This guide combines preparation parameters, assay workflows, cross-domain interpretation, and troubleshooting for reproducible oxidative stress research.
-
Baicalin: Pathways, Plasticity, and Cancer Research
2026-09-09
Baicalin is a Scutellaria baicalensis flavone glycoside with reported KEAP1-NRF2/HO-1 pathway modulation and preclinical activity in visual cortical plasticity and cancer research. A 2026 NeuroImage study found that 10 mg/kg baicalin restored ocular dominance plasticity in adult amblyopic mice, while the product dossier reports additional oncology-related pathway applications.
-
How GCG Disrupts SARS-CoV-2 Nucleocapsid Condensation
2026-09-08
The reference study identifies RNA-driven liquid–liquid phase separation of the SARS-CoV-2 nucleocapsid protein as a mechanistic step in viral biology. It further shows that the green-tea polyphenol (-)-gallocatechin gallate disrupts this condensation process and suppresses viral replication, providing a framework for studying viral condensates as chemical intervention points.
-
DFCP1, ATGL, and Starvation-Driven Lipolysis
2026-09-07
The reference study identifies DFCP1/ZFYVE1 as a nutrient-sensitive regulator of lipid droplet catabolism and defines its direct effect on ATGL behavior during starvation. Its key mechanistic insight is that DFCP1 recruits and retains ATGL on lipid droplets, limiting the dynamic lipase exchange required for efficient lipolysis.
-
Gamithromycin: From Ribosome to Translational Strategy
2026-09-07
Gamithromycin, also known as ML-1709460, is more than a macrolide antibiotic catalog entry: its value lies in the connection between 50S ribosomal inhibition, pulmonary exposure, and AUC24h/MIC-driven pharmacodynamics. This thought-leadership article translates the available rabbit pasteurellosis evidence into practical guidance for veterinary infection models, assay design, and translational development.